ME/CFS/FM, AIDS, GWI and Mycoplasma Infcetious Diseases I have Chronic Fatigue Immune Dysfunction Syndrome (CFS/CFIDS/ME) and HIV-NEGATIVE AIDS, idiopathic CD lymphocytopenia. With these two clinical diagnoses, I believe that makes me living proof that the AIDS-like CFS/ME is transmissible, something that the medical establishment seems unable to admit or to acknowledge. I also believe it makes me living proof that CFS and HIV-NEGATIVE AIDS are basically the same mysterious immune disorder. We at Max Resistance we’re shocked by this personal story of Karen Lambert, we are so pleased she contacted us to put her story forward and support her on this important journey. Dr. Nicolson noted that Mycoplasma infections in chronic Lyme disease are often overlooked by most doctors because they simply dont test for it. He states that those that do test for it find a much higher number of infected patients. Dr. Richard Horowitz, MD in New York finds a high incidence of M. fermentans, according to Dr. Nicolson. Sadly, however, even if patients are tested for Mycoplasma, a similar problem exists here as the one that almost all Lyme doctors and patients are aware of - namely that reliable tests do not exist. Dr. Nicolson notes that once a laboratory gets a reliable test in place, the laboratory is often shutdown. There are only a few labs left that test for Mycoplasma as a result. There might be misunderstood, misdiagnosed, mistreated or over looked. Mycoplasma is oftenly misunderstand as virus, because mycoplasma is smallest bacteria and behaves like virus. Regrettably, conventional diagnostic system has been helpful only for pneumonia, although it is critical turning point to find variegated Mycoplasma Infectious Diseases at an early stage for performing an effective medical protocol. Fortunately, the cutting-edge technology based on the mycoplasma species-specific glycolipid-antigens, has made it possible to measure the amount of specific antibodies. The new technology provides a reliable marker to follow the state of Mycoplasma Infectious Diseases, monitoring the fluctuations of antibody titers. I would like to introduce the novel therapeutic strategy for Mycoplasma Infectious Diseases. The cutting-edge technology has made it possible to measure the specific antibodies. The new diagnostics for “Mycoplasma Infectious Diseases” make it possible to monitor by measuring tiny fluctuations of antibody titers from zero. The new measuring methods, IgM, IgG, and IgA antibody amonts, using the mycoplasma species-specific glycolipid-antigens, are already established. ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgM antibodies ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgG antibodies ・Anti-Mycoplasma pneumonie-specific lipid-antigen IgA antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgM antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgG antibodies ・Anti-Mycoplasma fermentans-specific lipid-antigen IgA antibodies Mycoplasma Infectious Diseases is the systemic vasculitis/neuritis. It is not only pneumonia but also asthma, arthritis, nephritis, meningitis, encephalitis, dermatitis, pancreatitis, hepatitis, abnormalities in blood, so on. The concept of “Mycoplasma Infectious Diseases” is broad from acute to chronic phase with a variegated condition. Therefore, it is confusing and difficult to identify the mycoplasma-infected patient among those of incurable diseases, such as autoimmune diseases, a rheumatic disease, a nervous system disorder, and hematological disorders.
Posted on: Mon, 22 Sep 2014 01:55:04 +0000
Trending Topics
Recently Viewed Topics
© 2015